Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
Clinical trial NCT00538733 · COMPLETED
Trial details
- NCT number
- NCT00538733
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2010-07-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.